Literature DB >> 26759117

Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.

I Assunção-Miranda1, C Cruz-Oliveira2, R L S Neris1, C M Figueiredo1, L P S Pereira2, D Rodrigues1, D F F Araujo1, A T Da Poian2, M T Bozza1.   

Abstract

AIMS: To investigate the effect of heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX (CoPPIX and SnPPIX), macrocyclic structures composed by a tetrapyrrole ring with a central metallic ion, on Dengue Virus (DENV) and Yellow Fever Virus (YFV) infection. METHODS AND
RESULTS: Treatment of HepG2 cells with heme, CoPPIX and SnPPIX after DENV infection reduced infectious particles without affecting viral RNA contents in infected cells. The reduction of viral load occurs only with the direct contact of DENV with porphyrins, suggesting a direct effect on viral particles. Previously incubation of DENV and YFV with heme, CoPPIX and SnPPIX resulted in viral particles inactivation in a dose-dependent manner. Biliverdin, a noncyclical porphyrin, was unable to inactivate the viruses tested. Infection of HepG2 cells with porphyrin-pretreated DENV2 results in a reduced or abolished viral protein synthesis, RNA replication and cell death. Treatment of HepG2 or THP-1 cell lineage with heme or CoPPIX after DENV infection with a very low MOI resulted in a decreased DENV replication and protection from death.
CONCLUSIONS: Heme, CoPPIX and SnPPIX possess a marked ability to inactivate DENV and YFV, impairing its ability to infect and induce cytopathic effects on target cells. SIGNIFICANCE AND IMPACT OF THE STUDY: These results open the possibility of therapeutic application of porphyrins or their use as models to design new antiviral drugs against DENV and YFV.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  Dengue Virus; Yellow Fever Virus; antiviral; inactivation; metalloporphyrins

Mesh:

Substances:

Year:  2016        PMID: 26759117     DOI: 10.1111/jam.13038

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  13 in total

1.  Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX.

Authors:  Christine Cruz-Oliveira; Andreza F Almeida; João M Freire; Marjolly B Caruso; Maria A Morando; Vivian N S Ferreira; Iranaia Assunção-Miranda; Andre M O Gomes; Miguel A R B Castanho; Andrea T Da Poian
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Linking COVID-19 and Heme-Driven Pathophysiologies: A Combined Computational-Experimental Approach.

Authors:  Marie-Thérèse Hopp; Daniel Domingo-Fernández; Yojana Gadiya; Milena S Detzel; Regina Graf; Benjamin F Schmalohr; Alpha T Kodamullil; Diana Imhof; Martin Hofmann-Apitius
Journal:  Biomolecules       Date:  2021-04-27

Review 3.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

4.  Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope.

Authors:  Romulo L S Neris; Camila M Figueiredo; Luiza M Higa; Daniel F Araujo; Carlos A M Carvalho; Brunno R F Verçoza; Mariana O L Silva; Fabiana A Carneiro; Amilcar Tanuri; Andre M O Gomes; Marcelo T Bozza; Andrea T Da Poian; Christine Cruz-Oliveira; Iranaia Assunção-Miranda
Journal:  Sci Rep       Date:  2018-06-28       Impact factor: 4.379

5.  Zika Virus Infection Results in Biochemical Changes Associated With RNA Editing, Inflammatory and Antiviral Responses in Aedes albopictus.

Authors:  Maria G Onyango; Geoffrey M Attardo; Erin Taylor Kelly; Sean M Bialosuknia; Jessica Stout; Elyse Banker; Lili Kuo; Alexander T Ciota; Laura D Kramer
Journal:  Front Microbiol       Date:  2020-10-02       Impact factor: 5.640

6.  Possible Antiviral Activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline Coronavirus) Infection.

Authors:  Tomomi Takano; Kumi Satoh; Tomoyoshi Doki
Journal:  Front Vet Sci       Date:  2021-02-10

7.  Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2.

Authors:  Mya Myat Ngwe Tun; Takaya Sakura; Yasuteru Sakurai; Yohei Kurosaki; Daniel Ken Inaoka; Norifumi Shioda; Jiro Yasuda; Kiyoshi Kita; Kouichi Morita
Journal:  Trop Med Health       Date:  2022-01-07

8.  Antiviral Effects of 5-Aminolevulinic Acid Phosphate against Classical Swine Fever Virus: In Vitro and In Vivo Evaluation.

Authors:  Shizuka Hirose; Norikazu Isoda; Loc Tan Huynh; Taksoo Kim; Keiichiro Yoshimoto; Tohru Tanaka; Kenjiro Inui; Takahiro Hiono; Yoshihiro Sakoda
Journal:  Pathogens       Date:  2022-01-27

9.  Hydroxyl Radical Generation Through the Fenton-Like Reaction of Hematin- and Catechol-Functionalized Microgels.

Authors:  Pegah Kord Forooshani; Rattapol Pinnaratip; Elizabeth Polega; Ariana G Tyo; Eric Pearson; Bo Liu; Tinu-Ololade Folayan; Lei Pan; Rupak M Rajachar; Caryn L Heldt; Bruce P Lee
Journal:  Chem Mater       Date:  2020-09-04       Impact factor: 10.508

Review 10.  Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials.

Authors:  Rami A Al-Horani; Srabani Kar; Kholoud F Aliter
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.